An appraisal of 18-fluorodeoxyglucose positron emission tomography for melanoma staging

被引：10
|
作者：
Paquet, P
Henry, F
Belhocine, T
Hustinx, R
Najjar, F
Piérard-Franchimont, C
Piérard, GE
Rigo, P
机构：
[1] Univ Sart Tilman, Med Ctr, Dept Dermatopathol, Liege, Belgium
[2] Univ Sart Tilman, Med Ctr, Dept Nucl Med, Liege, Belgium
来源：
DERMATOLOGY | 2000年 / 200卷 / 02期
关键词：
melanoma; metastasis; positron emission tomography;
D O I：
10.1159/000018357
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Background: Positron emission tomography (PET scan) using fluorodeoxyglucose (FDG) is increasingly recognized as a reliable diagnostic method to detect metastases of malignant melanoma (MM). Objective: To compare the diagnostic:performance of 18-FDG PET scan to that of conventional imaging. Methods: A total of 28 assessments were conducted in 24 patients at risk of metastatic MM. Results: The diagnostic accuracy was over 80% and similar for PET scan and conventional imaging. Conclusion: Both the specificity and sensitivity of PET scan are high although not perfect. Confrontation of data with anatomical location and clinicopathological findings remains mandatory. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码：167 / 169
页数：3
相关论文
共 50 条
  • [1] Positron emission tomography with 18-fluorodeoxyglucose and sarcoma
    Carmoi, Thierry
    Bonardel, Gerald
    Gontier, Eric
    Algayres, Jean-Pierre
    [J]. PRESSE MEDICALE, 2010, 39 (12): : 1346 - 1347
  • [2] 18-Fluorodeoxyglucose positron emission tomography and pancreatic cancer
    Pedrazzoli, S
    Pasquali, C
    Sperti, C
    Chierichetti, F
    [J]. DIGESTIVE SURGERY, 2005, 22 (06) : 467 - 468
  • [3] The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer
    E de Winton
    A G Heriot
    M Ng
    R J Hicks
    A Hogg
    A Milner
    T Leong
    M Fay
    J MacKay
    E Drummond
    S Y Ngan
    [J]. British Journal of Cancer, 2009, 100 : 693 - 700
  • [4] Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest
    Bangerter, M
    Kotzerke, J
    Griesshammer, M
    Elsner, K
    Reske, SN
    Bergmann, L
    [J]. ACTA ONCOLOGICA, 1999, 38 (06) : 799 - 804
  • [5] The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer
    de Winton, E.
    Heriot, A. G.
    Ng, M.
    Hicks, R. J.
    Hogg, A.
    Milner, A.
    Leong, T.
    Fay, M.
    MacKay, J.
    Drummond, E.
    Ngan, S. Y.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (05) : 693 - 700
  • [6] 18-fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer
    Laking, G
    Price, P
    [J]. THORAX, 2001, 56 : 38 - 44
  • [7] 18-Fluorodeoxyglucose positron emission tomography and pancreatic cancer - Reply
    Ghaneh, P
    Neoptolemos, JP
    [J]. DIGESTIVE SURGERY, 2005, 22 (06) : 468 - 469
  • [8] 18-fluorodeoxyglucose positron emission tomography in initial diagnosis and staging of inflammatory breast tumors.
    Gutman, F
    Alberini, JL
    Lerebours, F
    Gonthier, E
    Wartski, M
    Al Nakib, M
    Brain, E
    Floiras, JL
    Pecking, AP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 51S - 51S
  • [9] The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer
    Davey, K.
    Heriot, A. G.
    Mackay, J.
    Drummond, E.
    Hogg, A.
    Ngan, S.
    Milner, A. D.
    Hicks, R. J.
    [J]. DISEASES OF THE COLON & RECTUM, 2008, 51 (07) : 997 - 1003
  • [10] Usefulness of 18-fluorodeoxyglucose positron emission tomography in pediatric neurology patients
    Molloy, PT
    Alavi, A
    Vaughan, SN
    Needle, M
    Haselgrove, JC
    Mosley, PD
    Phillips, PC
    [J]. ANNALS OF NEUROLOGY, 1996, 40 (02) : 107 - 107
12345